BR · Insider Trading
Broadridge Financial Solutions Inc
Every open-market purchase and sale reported by BR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Eileen K Murray | Director | A | +38 | — |
| 2026-10-06 | Amit Zavery | Director | A | +61 | — |
| 2026-10-06 | Robert N Duelks | Director | A | +146 | — |
| 2026-10-06 | Melvin L Flowers | Director | A | +18 | — |
| 2026-10-06 | Maura A. Markus | Director | A | +137 | — |
| 2026-10-06 | Annette L. Nazareth | Director | A | +40 | — |
| 2026-10-06 | Patricia Ann Mosconi | Director | A | +3 | — |
| 2026-10-05 | Thomas P Carey | Corporate VP | Sell | −2,501 | −$399.56K |
| 2026-10-05 | Douglas Richard Deschutter | Co-President ICS | F | −911 | −$146.81K |
| 2026-10-05 | Timothy C Gokey | CEO | F | −16,982 | −$2.74M |
| 2026-10-05 | Richard John Stingi | Corporate VP and CHRO | F | −1,109 | −$178.72K |
| 2026-10-05 | Christopher John Perry | President | F | −4,752 | −$765.78K |
| 2026-10-05 | Ashima Ghei | CFO | MIXED | +91 | −$50.76K |
| 2026-09-28 | Annette L. Nazareth | Director | A | +180 | — |
| 2026-09-28 | Eileen K Murray | Director | A | +389 | — |
| 2026-09-28 | Amit Zavery | Director | A | +180 | — |
| 2026-09-28 | Patricia Ann Mosconi | Director | A | +180 | — |
| 2026-09-28 | Maura A. Markus | Director | A | +209 | — |
| 2026-08-14 | Christopher John Perry | President | A | +9,308 | — |
| 2026-08-14 | Douglas Richard Deschutter | Co-President ICS | A | +1,783 | — |
| 2026-08-14 | Thomas P Carey | Corporate VP | A | +5,275 | — |
| 2026-08-14 | Ashima Ghei | CFO | A | +466 | — |
| 2026-08-14 | Timothy C Gokey | CEO | A | +33,265 | — |
| 2026-08-14 | Richard John Stingi | Corporate VP and CHRO | A | +2,172 | — |
| 2026-08-10 | Robert N Duelks | Director | Sell | −253 | −$48.73K |
| 2026-07-06 | Melvin L Flowers | Director | A | +18 | — |
| 2026-07-06 | Eileen K Murray | Director | A | +38 | — |
| 2026-07-06 | Amit Zavery | Director | A | +60 | — |
| 2026-07-06 | Annette L. Nazareth | Director | A | +39 | — |
| 2026-07-06 | Maura A. Markus | Director | A | +134 | — |
| 2026-07-06 | Patricia Ann Mosconi | Director | A | +3 | — |
| 2026-07-06 | Robert N Duelks | Director | A | +143 | — |
| 2026-06-29 | Ashima Ghei | CFO | MIXED | +1,604 | −$124.83K |
| 2026-06-11 | Annette L. Nazareth | Director | A | +206 | — |
| 2026-06-11 | Maura A. Markus | Director | A | +239 | — |
| 2026-06-11 | Eileen K Murray | Director | A | +445 | — |
| 2026-06-11 | Amit Zavery | Director | A | +206 | — |
| 2026-06-11 | Patricia Ann Mosconi | Director | A | +206 | — |
| 2026-06-05 | Hope M. Jarkowski | Chief Legal Officer | Sell | −1,966 | −$304.72K |
| 2026-04-09 | Robert N Duelks | Director | A | +127 | — |
| 2026-04-09 | Melvin L Flowers | Director | A | +16 | — |
| 2026-04-09 | brett keller | Director | A | +80 | — |
| 2026-04-09 | Maura A. Markus | Director | A | +116 | — |
| 2026-04-09 | Patricia Ann Mosconi | Director | A | +2 | — |
| 2026-04-09 | Eileen K Murray | Director | A | +29 | — |
| 2026-04-09 | Annette L. Nazareth | Director | A | +33 | — |
| 2026-04-09 | Amit Zavery | Director | A | +51 | — |
| 2026-04-08 | brett keller | Director | A | +177 | — |
| 2026-04-08 | Eileen K Murray | Director | A | +384 | — |
| 2026-04-08 | Annette L. Nazareth | Director | A | +177 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Timothy C Gokey | CEO | 159,159 | $28.38M |
| Richard J Daly | Executive Chairman | 118,489 | $21.13M |
| Christopher John Perry | President | 49,384 | $8.81M |
| Maura A. Markus | Director | 33,087 | $5.90M |
| Robert N Duelks | Director | 25,705 | $4.58M |
| Douglas Richard Deschutter | Co-President ICS | 17,135 | $3.06M |
| brett keller | Director | 16,942 | $3.02M |
| Annette L. Nazareth | Director | 9,816 | $1.75M |
| Amit Zavery | Director | 9,225 | $1.64M |
| Thomas P Carey | Corporate VP | 8,800 | $1.57M |
| Pamela L Carter | Director | 7,282 | $1.30M |
| Richard John Stingi | Corporate VP and CHRO | 6,571 | $1.17M |
| Laura Matlin | CVP, Deputy GC and CCO | 6,342 | $1.13M |
| Ashima Ghei | CFO | 6,286 | $1.12M |
| Eileen K Murray | Director | 6,185 | $1.10M |
| Melvin L Flowers | Director | 2,712 | $483.55K |
| Patricia Ann Mosconi | Director | 823 | $146.74K |
| Hope M. Jarkowski | Chief Legal Officer | 1 | $223 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BR quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.